Osteoporosis & bone health

An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures

Osteoporos IntPublished Retrospective cohort study

Main finding · Secondary fracturesResult — go to the resultOdds ratio 0.14 95% CI 0.03–0.66

Authors' conclusion

The OSLO-MOC has shown to be effective in reducing the rate of re-fracture and osteoporotic medication initiation and compliance of patients.

Study context

Population
Patients screened and treated for secondary osteoporotic fracture prevention at an orthopaedic surgical unit, 2008 to 20187,388 screened
Participants
2,855 patients
Exposure
Orthopaedic Surgeon Led Osteoporosis Model of Care vs Case Manager Led Osteoporosis Model of Care
  • OSLO-MOCn = 1,621
  • Case Manager Led Osteoporosis Model of Care (CMLO-MoC)n = 1,234reference
Outcome
Secondary fractures
Follow-up
12 months
Methodological detailssingle centre, comparative, logistic regression
  • Single centre
  • Comparative
  • Logistic regression

Main finding

As reported in the abstract

Odds ratio

0.14

95% CI 0.03–0.66

P = 0.013

OSLO-MOCvs CMLO-MoC
OR 0.14 (95% CI 0.03–0.66); P = 0.013

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)P value
Compliance to medication · 12 months2.61 (2.03–3.36)P < 0.001
Patient recruitment1.26 (1.06–1.49)P = 0.007
Compliance to medication — Higher level of education, OR (95%CI 1.02-1.43), P = 0.037
1.428

Original publication

An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures. Osteoporos Int. Published 21 November 2022. doi:10.1007/s00198-022-06595-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.